Australian University Rankings Guide

ChemMedChem: chemistry enabling drug discovery (ERA Journal)

ChemMedChem: chemistry enabling drug discovery is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

ChemMedChem: chemistry enabling drug discovery issns are issn1: 1860-7179 issn2: 1860-7187.

The fields covered by ChemMedChem: chemistry enabling drug discovery as part of the evaluation of Australian university research excellence are:

Medicinal and Biomolecular Chemistry Research Rankings (Sub-Field)

Organic Chemistry Research Rankings (Sub-Field)

Pharmacology and Pharmaceutical Sciences Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Medicinal and Biomolecular Chemistry field include:

- Anti-Cancer Drugs: international journal on anti-cancer agents
- Bioorganic and Medicinal Chemistry Letters
- Current Medicinal Chemistry
- Current Opinion in Chemical Biology
- Drugs in R and D
- European Journal of Medicinal Chemistry
- Free Radical Biology and Medicine
- Heterocycles
- International Journal of Molecular Medicine
- Magnetic Resonance in Chemistry
- Molecular Medicine Reports
- Peptides
- Phytochemistry Letters
- Tetrahedron: the international journal for the rapid publication of full original research papers and critical reviews in organic chemistr
- Vibrational Spectroscopy


ERA Research Rankings Submenu


- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List



Latest News and Updates:


- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4